Haloperidol for Pain Control in Patients With Acute Musculoskeletal Back Pain in the Emergency Department

Description

Single center, double-blind, randomized, controlled trial in patients who present to the emergency department (ED) with a chief complaint of back pain. A total of 150 patients age 18-65 presenting to the emergency department with chief complaint of backpain will be enrolled from April 2024 - April 2025. Patients will be randomized and symptom levels will be recorded at 30, 60, 90, minutes. Follow-up will be performed by telephone at 24 hours.

Conditions

Back Pain, Chronic Pain

Study Overview

Study Details

Study overview

Single center, double-blind, randomized, controlled trial in patients who present to the emergency department (ED) with a chief complaint of back pain. A total of 150 patients age 18-65 presenting to the emergency department with chief complaint of backpain will be enrolled from April 2024 - April 2025. Patients will be randomized and symptom levels will be recorded at 30, 60, 90, minutes. Follow-up will be performed by telephone at 24 hours.

Haloperidol for Pain Control in Patients With Acute Musculoskeletal Back Pain in the Emergency Department

Haloperidol for Pain Control in Patients With Acute Musculoskeletal Back Pain in the Emergency Department

Condition
Back Pain
Intervention / Treatment

-

Contacts and Locations

Kalamazoo

Bronson Methodist Hospital, Kalamazoo, Michigan, United States, 49007

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Age 18 - 65 years old
  • * Presenting to the Bronson ED with a chief complaint of acute, non-traumatic back pain
  • * VAS score \>5 cm
  • * Back pain due to traumatic injury
  • * Experiencing saddle anesthesia
  • * Has bowel or bladder dysfunction
  • * Has an abnormal neurological exam
  • * Requires imaging in ED
  • * Has a Glascow coma score \<15
  • * Has one or more abnormal vital signs:
  • * Has an allergy to ketorolac or haloperidol
  • * Has a known diagnosis of Lewy Body Dementia
  • * Has a known diagnosis of glaucoma.
  • * Is known to be pregnant or breastfeeding
  • * Is a prisoner or ward of the state
  • * Is unable to consent for themselves/ non-english speaking
  • * In the opinion of the attending physician or investigator the patient should not participate in the research

Ages Eligible for Study

18 Years to 65 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Western Michigan University School of Medicine,

Jessica McCoy, MD, PRINCIPAL_INVESTIGATOR, Western Michigan University Homer Stryker M.D. School of Medicine

Study Record Dates

2027-04-15